Vishwas Bhatia
About Vishwas Bhatia
Vishwas Bhatia serves as the Director of Analytical Research & Development at Ocugen, where he has worked since 2021. With over 16 years of experience in biotech, immunology, and microbiology, he specializes in developing assays and supporting gene therapy products.
Work at Ocugen
Vishwas Bhatia serves as the Director of Analytical Research & Development at Ocugen, a position he has held since 2021. In this role, he is based in Philadelphia, Pennsylvania, and is responsible for leading initiatives in the development and qualification of analytical methods for gene therapy products. His work involves overseeing process development, scale-up, technology transfer, and providing support for GMP manufacturing, ensuring that all products meet stringent quality and safety standards.
Education and Expertise
Vishwas Bhatia has a robust educational background in biotechnology. He earned a Ph.D. from CMJ and holds a Master's degree from Punjabi University, as well as a Master of Science from Stratford University. His academic training has equipped him with extensive knowledge in biotech, immunology, and microbiology, which he applies in his professional roles. Bhatia has over 16 years of experience in research and development, focusing on analytical methods and product development in the biotech sector.
Background
Before joining Ocugen, Vishwas Bhatia worked at Thermo Fisher Scientific as a Senior Scientist (Lead) from 2019 to 2021. He also held a position as a Senior Scientist at uniQure from 2018 to 2019. His earlier experience includes a role as a Scientist at Ranbaxy from 2006 to 2007. This diverse background in various organizations has provided him with a comprehensive understanding of the biotech industry and its analytical research needs.
Achievements
In his current role, Vishwas Bhatia leads the development and qualification of various analytical methods, including cell-based potency assays and droplet digital PCR methods specifically for adeno-associated virus (AAV)-based gene therapy products. He collaborates with cross-functional teams to design and execute experiments, leveraging his expertise to identify industry trends and evaluate competitive products, thereby contributing to innovative solutions in the gene therapy market.